- Jaiprakash
Associates(JPA IN) | TP Revision
- Bumi
Serpong Damai (BSDE IJ) | Results Review
- AKR
Corporindo Tbk (AKRA IJ) | Results Review
- Bekasi
Fajar (BEST IJ) | Results Review
- Kimia
Farma (KAEF IJ) | Results Review
- Yinson
Holdings (YNS MK) | Company Update
- Malaysia
Airports Holdings (MAHB MK) | Results Review
- IGB
REIT (IGBREIT MK) | Results Review
- Public
Bank (PBK MK) | Results Review
- RFM
Corp (RFM PM) | Results Review
- Keppel
Corp (KEP SP) | Results Review
- Erawan
Group (ERW TB) | Result Preview
- Semen
Indonesia (SMGR IJ) | Company Update
|
Jaiprakash Associates(JPA IN)
|
Power plant sale deal cancelled
|
Share Price: INR62 | Target
Price: INR93(+50%) | MCap (USD): 2.3B | ADTV (USD): 46M
|
- In a
surprise move, TAQA (Abu Dhabi based investor) withdrew from
the deal to acquire JPA's two hydro power plants worth INR96b
signed in Mar '14.
- This
would delay JPA's debt reduction plans by 6-9 months. JPA
would have cut debt by 18% by Nov' 14. The company said it
would look for new investors for this sale.
- We
are not concerned about JPA's ability to service the debt
since EBITDA of INR15b from these plants is more than
sufficient to pay interest. We cut our SOTP-based TP by 10% to
INR93 (earlier TP was INR104) because debt would be high as of
Mar '16. We think yesterday's 6% correction in stock price
factors in this development and maintain BUY.
- (Full
note will be out soon)
|
Bumi Serpong Damai (BSDE IJ)
|
2Q net in line; Top BUY
|
Share Price: IDR1,650 | Target
Price: IDR1,800(+9%) | MCap (USD): 2.5B | ADTV (USD): 2M
|
- 2Q14
earnings of IDR2.08t (+324% QoQ), boosted by IDR1.58t
extraordinary income. 1H14 earnings IDR2.56t (+67% YoY).
- Organic
1H14 earnings of IDR983b, in line with our estimate (49%) and
consensus (47%).
- Reiterate
BUY, top sector pick with TP of IDR1,800 (38% discount to RNAV
of IDR2,898).
|
AKR Corporindo Tbk (AKRA IJ)
|
2Q earnings better than expected
|
Share Price: IDR4,435 | Target
Price: IDR5,500(+24%) | MCap (USD): 1.5B | ADTV (USD): 3M
|
- Maintain
BUY, TP IDR5,500 on structural reform in economy.
- 2Q14
earnings of IDR196b topped our estimate, driven by margin
expansion in the fuel business, higher fuel sales volume and
lower tax rate.
- Fuel
sales volume rose5.4% QoQ on the back of strong growth in
subsidized fuel volume.
|
Bekasi Fajar (BEST IJ)
|
2Q missed, FY15-16 positive: BUY
|
Share Price: IDR590 | Target
Price: IDR650(+10%) | MCap (USD): 494M | ADTV (USD): 1M
|
- 1H14
earnings of IDR125b (-53% YoY) make up only 20% of our and
consensus expectations.2Q14 earnings of IDR34b down 63% QoQ.
- Management
stated it is experiencing delays in recognizing revenues and
it may cut its FY14F revenue target to IDR800b from IDR1,200b.
- Maintain
BUY with TP of IDR650 as we expect FDI to return in 2015. BEST
major beneficiary as it has ample land reserves.
|
Kimia Farma (KAEF IJ)
|
6M14 results above estimates
|
Share Price: IDR975 | Target
Price: IDR1,200(+23%) | MCap (USD): 448M | ADTV (USD): 0.4M
|
- 6M14
net earnings up 65% YoY to IDR71bn, above expectations (30% of
our FY14F earnings forecast). TP under review.
- Revenue
growth continued, up 19% QoQ. We believe this was due to the
impact of National Health Insurance.
- EBIT
margin expanded 450bps vs 1Q14, mainly on cost efficiencies
from restructuring of its distribution business.
- (Full
report will be out soon)
|
Yinson Holdings (YNS MK)
|
Sells Petroleo Nautipa for USD59m
|
Share Price: MYR2.95 | Target
Price: MYR3.03 (+3%) | MCap (USD): 1.0B | ADTV (USD): 1.3M
|
- A
good deal, set to make MYR79mgain from this transaction.
- Short-term
earnings dilution; proceeds to be channelled for new
opportunities that would enhance values and earnings.
- Reiterate
BUY and MYR3.03TP(19xFY1/16 PER target).
|
Malaysia Airports Holdings (MAHB
MK)
|
Surprise loss
|
Share Price: MYR7.60 | Target
Price: MYR6.90 (-9%) | MCap (USD): 3.3B | ADTV (USD): 4.5M
|
- 2Q14
core net loss was a negative surprise. Depreciation soared,
followed by utilities and mantainence costs.
- Forecasts
reviewed, TP lowered to MYR6.90.
- Share
price has however weakened ahead; upgrade to HOLD (from SELL).
|
IGB REIT (IGBREIT MK)
|
Beat expectations
|
Share Price: MYR1.26 | Target
Price: MYR1.29 (+2.4%) | MCap (USD): 1.4B | ADTV (USD): 0.4M
|
- 1H14net
profit of MYR116m was above our expectations but in line with
consensus full-year estimates.
- RaiseFY14/15/16
earnings forecasts by 4%/5%/5% and DCF-based TP by +5sen to
MYR1.29.
- Lacks
strong pipeline assets to re-rate over the short-term. HOLD.
|
Public Bank (PBK MK)
|
Tepid growth in 1HFY14
|
Share Price: MYR20.00 | Target
Price: MYR19.20(-4%) | MCap (USD): 24.5B | ADTV (USD): 38M
|
- 1HFY14
net profit rose just 4% YoY; marginally behind expectations
due to a larger contraction in NIMs.
- Domestic
loan growth within 10-11% target but NIM to still contract
10-12 bps in FY14.
- SELL
maintained on pricey valuations and declining ROEs �TP unchanged at MYR19.20
(FY15 P/BV of 2.4x).
|
RFM Corp (RFM PM)
|
Logistical issues softened 2Q
results
|
Share Price: PHP5.68 | Target
Price: PHP7.00(+23%) | MCap (USD): 460M | ADTV (USD): 0.1M
|
- 1H14
earnings of PHP427m up 10% YoY as sales grew 8% to PHP5b,
accounting for 42% and 43% of our full- year forecasts.
- Sales
and earnings growth slightly accelerated in 2Q14 and expected
to further improve in 2H14.
- Maintain
BUY with forecasts and PHP7 TP unchanged for now.
- (Full
report will be out soon)
|
Keppel Corp (KEP SP)
|
Holding its ground
|
Share Price: SGD10.93 | Target
Price: SGD10.95 (+0%) | MCap (USD): 16.0B | ADTV (USD): 22M
|
- 2Q14
results met expectations. O&M operating margin rose by
0.3ppt to 14.5%, on track to meet our full-year forecast.
- An
oversupplied deepwater rig market and reduced capex by oil
companies could cap share price upside.
- Maintain
HOLD with revised SOTP-based TP of SGD10.95.
|
Erawan Group (ERW TB)
|
Bottomed in 2Q, Rebound in 2H
|
Share Price: THB4.82 | Target
Price: THB6.00(+24%) | MCap (USD): 380M | ADTV (USD): 1M
|
- Occupancy
rate in 2Q14 expected to reach 61% (65% in 1Q14, 76% in 2Q13),
and ADR to increase 3% YoY. RevPAR expected to decline 18% QoQ
and 20% YoY.
- Forecast
net loss of THB81m, from break-even in 1Q14 and NP THB731m in
2Q13. Consensus expects THB45m net loss.
- Maintain
BUY with new DCF-based TP of THB6.0 at 10% WACC and 3%
terminal growth. Medium-term outlook remains positive and
expect earnings turnaround in 2015.
- (Full
report will be out soon)
|
Semen Indonesia (SMGR IJ)
|
Strong 2Q14 earnings
|
Share Price: IDR16,875 | Target
Price: IDR17,100(+1%) | MCap (USD): 8.7B | ADTV (USD): 13M
|
- 2Q14
earnings grew 30.1% QoQ boosted by volume recovery and lower
costs. As such, margins improved as well.
- 1H14
earnings were slightly higher than our forecast.
- Maintain
BUY and TP of IDR17,100.
- (Full
note will be out soon)
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.